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Abstract
Background: The impact of percutaneous dilatational tracheostomy (PDT) on the development of post-median
sternotomy wound infection (SWI) and mediastinitis is still controversial. We aimed to investigate the frequency of
cross-infection and incidence of SWI after PDT.
Methods: In a retrospective design, out of a total of 4100 procedures, all patients who had undergone median
sternotomy and postoperative PDT were included from January 2010 to May 2013. For comparison of the pathogens
isolated from SWIs, data from all patients who developed an SWI without a PDT during the aforementioned period
were also analyzed. Demographical, pre-, peri- and post-operative data were compared. Microbiologic analysis
from cultures of sternal and tracheal wounds was performed. Day and duration of tracheostomy were correlated
to SWI occurrence.
Results: Of the 265 patients who underwent a PDT, 25 (9.4 %) developed an SWI. In this cohort, identical pathogens
were isolated from the tracheostomy and SWI in 36 % (9/25) of the patients. Of the pathogens isolated from the SWIs
from the PDT + SWI group, 60 % were gram-positive bacteria, 20 % gram-negative bacteria and 20 % Candida spp. In the
cross-infection group, the patients developed the following types of SWIs: 11.1 % CDC I, 55.6 % CDC II and 33.3 %
mediastinitis (CDC III). The incidence of SWI in the group SWI + PDT was 9.4 % (9.4 % vs. 3.4 %, PDT + SWI and
SWIw/oPDT, respectively, p = 0.0001). In group SWIw/oPDT, only 1.5 % (2/131 vs. 5/25; p = 0.001) Candida spp were
isolated from SWI. The infection-related in-hospital mortality was high in groups PDT + SWI vs. SWIw/oPDT (20 % vs. 0 %,
respectively; p = 0.0001). The statistical analysis did not demonstrate any correlation between time of performing PDT
and occurrence of SWI.
Conclusions: There was a high incidence of microbial cross-infection from the PDTs to the sternal wounds in our
study. We did not detect any correlation between the time of performing PDT and occurrence of SWI. According to
our data, PDT seems to increase the incidence of SWI, especially caused by Candida spp., after cardiac surgery, which
results in a prolonged hospital stay. Therefore, early antifungal prophylaxis after a PDT might be reasonable in high-risk
patients on long-term mechanical ventilation if there is an impending SWI.
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Background
Sternal wound infection (SWI) and mediastinitis are dev-
astating complications in cardiac surgery patients and are
associated with high mortality rates between 10 and 50 %
[1–4]. The incidence of deep sternal wound infection
(DSWI) and mediastinitis have been reported to range be-
tween 0.16–3.20 % and 1–3 %, respectively [1, 3, 4]. The
most common microbiological pathogens found in in-
fected sternal wounds are gram-positive staphylococci
(Staphylococcus aureus and coagulase-negative staphylo-
cocci) followed by gram-negative species [5–10]. Candida
spp. were also isolated from SWIs and prevalent in pa-
tients on long-term mechanical ventilation.
In this retrospective study, we aimed to investigate the
incidence of SWIs after percutaneous dilatational trache-
ostomies (PDTs), the frequency of cross-infection and if
a PDT changed the microbial strains involved in an SWI.
Methods
From January 2010 to May 2013, 4100 cardiac surgery
procedures through median sternotomy were performed
at our institution. All cardiac surgery patients who had
undergone cardiac surgery with a full median sternot-
omy and required a postoperative PDT were included in
this retrospective study.
A PDT was performed within a monitored time win-
dow in 271 of 4100 patients undergoing full-sternotomy
cardiac surgery in our unit. Of these 271 patients, six pa-
tients who developed SWI prior to PDT were excluded
from the study. From the remaining 265 patients, 25
(9.4 %) developed an SWI or mediastinitis post-PDT
(group PDT + SWI, n = 25). For comparison of the patho-
gens isolated from SWIs, data from all patients who devel-
oped an SWI without a PDT during the aforementioned
period were also analyzed (group SWIw/oPDT, n = 131)
(Fig. 1). EuroSCORE II and The Society of Thoracic
Surgeons’ risk models (STS) scores were calculated for all
patients. All patients with SWI were followed up routinely
in our out patient clinic for 6 weeks after discharge from
the hospital. The study protocol was cleared by the local
ethical committee, Ethik-Kommission an der Medizinischen
Fakultät der RWTH Aachen (KEK). Due to the retrospective
character of this observational study, informed consent
was waived by the local board at the Medical Faculty
RWTH Aachen.
Procedural routine
All the patients underwent a similar pre-operative assess-
ment and variety of cardiac procedures using standard
median sternotomy. All the patients undergoing cardiac
surgery in our department routinely receive Mupirocin
nasal ointment on the day before operation and a single
shot of peri-operative prophylactic antibiotics with either
ampicillin/sulbactam (Unacid®) or, if a patient has a peni-
cillin allergy, clindamycin.
According to our institutional standard operating proce-
dures, tracheostomies were performed in patients who
failed extubation twice or when patients were not ex-
pected to be extubated within 10 days. All PDTs were per-
formed by an experienced team of anesthesiologists in the
ICU using the Frova technique (RÜSCH Tracheostomy,
Teleflex Medical GmbH, Kernen, Germany).
Data assessment
The following data were collected for all the patients: pre-
operative, peri-operative and post-operative parameters,
duration of intubation, duration of mechanical ventilation,
microbiological findings from tracheal secretions, occur-
rence of SWI, all-cause in-hospital mortality and infection-
related in-hospital-mortality, microbiological findings from
sternal wound, common pathogens isolated from the
sternal wound and tracheostoma, post-operative day
on which PDT was performed, and the duration of
ventilation through PDT.
Cardiac surgery procedures 
through median sternotomy 
n = 4100 
SWI without PDT 
n = 131 
Post operative PDT 
n = 271 
SWI post PDT 
n = 25 
Cross infection 
n = 9 
PDT without SWI 
n = 240 
SWI prior to PDT 
n = 6 
Fig. 1 Classification of patients in groups
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Sternal wound infections and mediastinitis were classi-
fied according to the guidelines of the Centers for Disease
Control and Prevention (CDC) [11] as follows: superficial
sternal wound infection SSWI (CDC I), deep sternal
wound infection DSWI (CDC II) and mediastinitis
(CDC III). Aspirates from tracheal secretions were
routinely collected and sent for microbiological analysis
before or on the day a PDT was performed as well as the
second or third day after the PDT procedure. In cases of
infection, samples were taken at least two times a week.
An SWI was diagnosed by a clinical examination (signs
of local infection, drainage of pus, fistulas and fever), com-
puted tomography (CT) scans (retrosternal fluid collection
and sternal dehiscence) and lab findings (leucocytosis and
C-reactive protein). In all cases, the diagnosis was con-
firmed by microbiological findings. Wound swabs were
taken before debridement and wound cleansing and sent
for microbiological culture diagnostics. Once a medias-
tinal infection was evident, appropriate antibiotics were
administered based on culture and sensitivity results.
Statistics
Data analysis was performed with SPSS 20 (IBM, Chicago,
IL, USA). Continuous variables were compared with
means ± SD using Student´s t-test. Categorical variables
were analyzed with a Chi-Square test or, if appropriate,
Fisher’s exact test. Mortality at defined time points and in-
cidence of SWIs were compared using a Chi Square test.
Incidence of SWIs in relation to a categorized time point
after a PDT procedure and duration of respiratory therapy
were analyzed using Pearson’s chi-squared test (χ2).
All p-values were reported as three digit numbers or




In group PDT + SWI, both the EuroScore II and STS
scores indicated that most of the patients were high risk.
The groups PDT + SWI and SWIw/oPDT differed signifi-
cantly in many known risk factors (Table 1): mean body
mass index (BMI), p = 0.034; peripheral arterial disease
(PAD), p = 0.0005 and renal insufficiency, p = 0.029; pre-
operative intra-aortic balloon pump (IABP), p = 0.024;
and pre-operative inotrope therapy, p = 0.013. Group
PDT + SWI had a higher mean EuroSCORE II score
than group SWIw/oPDT (18.81 vs. 4.0, respectively, p =
0.0001), a higher mean STS score for risk of mortality
(6.5 vs. 2.2, respectively, p = 0.0001), and no significant
difference in mean STS score for risk of DSWI (0.6 vs.
0.5, respectively, p = 0.231). Group SWIw/oPDT included
more patients who underwent CABG surgery than group
PDT + SWI (71.8 % vs. 48.0 %, p = 0.033). There were no
differences in perioperative variables between both groups.
Only the mean cardiopulmonary bypass time (CPB)
(p = 0.013) was significantly longer in group PDT+ SWI.
Infection rates and mortality
During the study period, the overall incidence of SWI
was 3.8 % (156/4100 cardiac surgery procedures with a
full median sternotomy) with a low incidence of medias-
tinitis (0.56 %; 23/4100). In group PDT + SWI, the inci-
dence of SWI was significantly higher than in group
SWIw/oPDT with 9.4 % versus 3.4 %, respectively; p =
0.0001 (Table 2). In both groups, most cases of SWI and
mediastinitis were detected within the first 30 post-
operative days (72 % in group PDT + SWI and 84 % in
group SWIw/oPDT). In group PDT + SWI, five patients
died because of mediastinitis-related septic multi-organ
failure, compared to group SWIw/oPDT in which no
infection-related in-hospital mortality was detected
(20 % vs. 0 %, respectively; p = 0.0001). All-cause in-
hospital mortality was significantly higher in group
PDT + SWI than in group SWIw/oPDT (48 % vs. 3.8 %,
respectively; p = 0.0001) (Fig. 2).
Microbiological findings
Figure 3 demonstrates the microbiological pathogens
isolated from tracheal secretions of the patients who re-
ceived a PDT. In group PDT + SWI, identical pathogens
were isolated from the tracheostomy and sternal wounds
of nine (36 %) patients. The majority of patients with a
post-operative SWI or mediastinitis had polymicrobial
infections. The common pathogens isolated from the
tracheal secretions and sternal wounds are shown in
Fig. 4. In nine patients, the cross-infection SWIs were
classified as follows: 11.1 % CDC I, 55.6 % CDC II and
33.3 % mediastinitis (CDC III). One patient with cross-
infection died because of mediastinitis-related septic
shock. The common cross-infection pathogen was
Candida albicans.
Pathogens isolated from the SWI in groups PDT + SWI
and SWIw/oPDT are outlined in Table 3. In our study, the
incidence of Candida spp. infections was significantly
higher (20 % vs. 1.5 %, p = 0.001) in group PDT+ SWI
than group SWIw/oPDT. However, the incidence of S.
aureus infections (8 % vs. 29 %, p = 0.05) was significantly
higher in group SWIw/oPDT than group PDT + SWI.
Incidence of SWI in relation to the time after PDT
procedure and duration of respiratory therapy
During the first post-operative week, 207 patients re-
ceived a PDT, and 20 patients in this group developed
an SWI. During the second post-operative week, 49 pa-
tients underwent a PDT, and four developed an SWI.
During the third week, a PDT was performed in nine pa-
tients; one developed an SWI (Fig. 5). After analyzing
the relation of the incidence of SWIs to the categorized
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Table 1 Demographics and clinical data
PDT + SWI (n = 25) SWI w/o PDT (n = 131) P-values
Preoperative variables
Mean age (±) SD 70 (±6.4) 66 (±11) 0.080
Mean BMI (±) SD 26.8 (±3.93) 28.9 (±4.6) 0.034
Female % (n) 36.0 (9) 44.3 (58) 0.511
Preop. LVEF < 34 % (n) 20.0 (5) 4.6 (6) 0.729
NYHA IV % (n) 36.0 (9) 14.5 (19) 0.420
Hypertension % (n) 88.0 (22) 93.9 (123) 0.385
DM % (n) 32.0 (8) 42.0 (55) 0.383
COPD % (n) 36.0 (9) 24.4 (32) 0.226
PAD % (n) 48.0 (12) 14.5 (19) 0.0005
Smoking % (n) 48.0 (12) 47.3 (62) 1.000
Recent MI % (n) 44.0 (11) 42.7 (56) 1.000
Renal insufficiency % (n) 68.0 (17) 43.5 (57) 0.029
Preop. IABP % (n) 8.0 (2) 0 0.024
Preop. Inotropes % (n) 16.0 (4) 2.2 (3) 0.013
Preop. Dialysis % (n) 4.0 (1) 0.7 (1) 0.295
Mean Euroscore II in % (±) SD 18.8 (±15.6) 4.0 (±4.6) 0.0001
Mean STS-score: Risk of Mortality % (±) SD 6.5 (±4.3) 2.2 (±2.1) 0.0001
Mean STS-score: Risk of DSWI % (±) SD 0.6 (±0.26) 0.5 (±0.4) 0.231
Operative procedures
CABG % (n) 48.0 (12) 71.8 (94) 0.033
Comb. CABG + Valve % (n) 12.0 (3) 16.0 (21) 0.768
Valve surgery % (n) 8.0 (2) 1.5 (2) 0.120
Thoracic aorta proc. % (n) 16.0 (4) 4.6 (6) 0.055
VAD-Implantation % (n) 8.0 (2) 0.8 (1) 0.067
Re-do % (n) 8.0 (2) 5.3 (7) 0.637
Perioperative variables
Mean Cross-clamp time (min) 58.6 (±44.0) 59.0 (±36.1) 0.961
Mean CPB time (min) 133.8 (±59.5) 103.8 (±54.3) 0.013
Postoperative Variables
Re-thoracotomy (%) 20 (5) 9.2 (12) 0.153
Stroke (%) 12 (3) 0 0.003
Low cardiac output (%) 20 (5) 0 0.0001
Pneumonia % (n) 68 (17) 13.7 (18) 0.0001
Respir. Insufficiency % (n) 84 (21) 19.0 (25) 0.0001
Delirium % (n) 56 (14) 22.9 (30) 0.001
Post-op MI % (n) 0 1.5 (2) 1.000
Sepsis 60 (15) 13.7 (18) 0.0001
Mean vent. time in (h) (±) SD 547 (±288) 21 (±37) 0.0001
Mean number of packed RB cells (±) SD 11 (±11) 3 (±2) 0.0001
Mean days of ICU-stay (±) SD 32 (±11) 7 (±8) 0.0001
Mean LOS hospital (±) SD 40 (±14) 36 (±18) 0.294
Description of pre-, peri-, post-operative clinical characteristics, surgical techniques and intensive care unit stays
Bold writing indicates significant values
BMI body mass index (kg/m2), LVEF left ventricle ejection fraction, NYHA New York Heart Association, COPD chronic obstructive pulmonary disease, DM diabetes
mellitus, PAD peripheral arterial disease, Recent MI recent myocardial infarction, Preop pre-operative, IABP intra-aortic balloon pump, CABG coronary artery bypass
graft, Other other open heart surgery procedures, CPB time total cardiopulmonary bypass time (in min), Valve heart valve surgery, VAD ventricular assist device
implantation, Re-do second heart surgery, SD standard deviation, LOS length of stay, ICU intensive care unit; packed RB cells packed red blood cell
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time point of PDTs and duration of respiratory therapy
using Pearson’s Chi-squared test, no correlation was
detected between the time of performing a PDT and
SWI (p = 0.963, Fig. 6). However, there was a correlation
(p = 0.0001) between the duration of ventilation through
a PDT and occurrence of an SWI (Fig. 6).
Discussion
Clinical relevance of the bacterial strains
In group SWIw/oPDT, the most frequently isolated patho-
gens from SWIs were gram-positive staphylococci (CNS
40 %, followed by S. aureus 29 %). These findings are con-
sistent with numerous studies [5–10]. In these studies, the
incidence of fungi in SWI was reported to range between
1 and 5 %. In our group PDT+ SWI, the incidence of S.
aureus was significantly lower than group SWIw/oPDT. On
the other hand, Candida spp. were isolated from 20 % of
the SWIs after PDT. Candida spp. were also isolated from
tracheal secretions in 53.6 % of the patients who had a
PDT, as well as in 38 % of the patients who had cross-
infection between the PDT and SWI. Five patients with an
SWI due to Candida spp. contamination had the longest
hospital stays (45 ± 15 days). One of them died during the
first 30 POD from shock and multiorgan failure related to
mediastinitis. The low incidence of S. aureus in SWI +
PDT and subsequent high rate of candida spp. might be
related to the fact that these patients already suffered a
long term intensive care stay with multiple complications
requiring long term antibiotics.
Our findings are consistent with the study from
Modrau et al. [7]. They found that when cardiothoracic
patients on mechanical ventilation are tracheally colonized
with Candida spp., they have a high-risk for subsequently
developing Candida DSWI. Additionally, patients who de-
veloped SWI with Candida spp. had a significantly higher
mortality rates and longer ICU stays.
The patients who required a PDT were critically ill
patients with postoperative complications such as pneu-
monia requiring long-term antibiotic therapy. Pittet
et al. [12] identified the length of antibiotic therapy, se-
verity of illness and degree of Candida spp. colonization
as factors that predicted subsequent Candida infections.
A Cochrane Review suggested that antifungal prophy-
laxis should be considered in non-neutropenic critically
ill patients [13].
Cross-infection
We found cross-infection in nine (36 %) patients with an
SWI after a PDT. These findings may be controversial
because several previous studies did not find any cor-
relation between early PDT and SWIs [14–16]. Com-
pared with an open surgical tracheostomy, a PDT
causes less microbial contamination at the tracheos-
tomy site [17, 18]. Whether the PDT technique pre-
vents microbiological cross-infection of an adjacent
sternal wound remains a controversial matter.
Tracheostomy as a risk factor
Prolonged mechanical ventilation after cardiac surgery is
an unfortunate adverse event occurring in patients suf-
fering respiratory failure. This can be due to a variety of
reasons, pneumonia being the most common.
Sun et al. [19] reported tracheostomy as an independ-
ent risk factor for SWI. On the other hand, cardiac
surgery patients who require prolonged mechanical ven-
tilation benefit from tracheostomy [20, 21] because of a
reduced level of sedation and facilitated weaning from
ventilator support, which results in a reduced incidence of
Table 2 Incidence of SWI in group PDT + SWI vs. group SWI
w/o PDT
PDT + SWI (n = 25) SWI w/o PDT (n = 131) P-Values
SWI % (n) 9.4 % (25/265) 3.4 % (131/3829) 0.0001
CDC I % (n) 20 % (5) 1.5 % (2)
CDC II % (n) 52 % (13) 86.3 % (113)
CDC III % (n) 28 % (7) 12.2 % (16)
Bold writing indicates significant Values
CDC Centers for Disease Control and Prevention, SWI sternal wound infection
Fig. 2 All-cause in-hospital mortality and infection-related in-hospital mortality. *p = 0.0001
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ventilator-associated pneumonia [22, 23]. PDT has become
a standard procedure in cardiac surgery patients who have
a high risk for post-operative pulmonary complications
and replaced open surgical tracheostomy [17, 24]. A PDT
is easy to perform, safe cost-effective and can be performed
at bedside [17, 24]. However, some authors state that a
PDT does not increase the risk for an SWI following a me-
dian sternotomy, even when the PDT is carried out in the
first post-operative week [16, 17, 25]. In accordance with
Byhahn et al., Hubner et al. and Gaudino et al. [14, 15, 25],
we found that there was no correlation between an early
postoperative PDT and the development of SWI. From a
clinical point of view, we strongly support Byhahn et al.,
Stamenkovic et al. and Gaudino et al. [14, 16, 25] who con-
cluded that the indisputable advantages of early PDT far
outweigh the potential risks of promoting an SWI. How-
ever, according to our findings, early antifungal prophylaxis
when an SWI is imminent might be reasonable in high-
risk patients with a PDT to avoid dire complications of a
candida wound infection.
Limitations of study
One of the main limitations of the presented study is its
retrospective design, although prospective designs can
Fig. 3 Bacteria isolated from tracheal secretions in group PDT + SWI. MRSA: Methicillin-resistant Staphylococcus aureus; CNS: Coagulase negative
staphylococci; E. coli: Escherichia coli; others: described in Table 3
Fig. 4 Common pathogens isolated from tracheostomas and sternal
wounds. MRSA: Methicillin-resistant Staphylococcus aureus; CNS:
Coagulase negative staphylococci; E. coli: Escherichia coli
Table 3 Pathogens isolated from SWIs
PDT + SWI SWI w/o PDT P-values
MRSA 8 % (2) 4.6 % (6) 0.615
Staphylococcus aureus 8 % (2) 29 % (38) 0.026
CNS 32 % (8) 40 % (52) 0.516
Enterococcus spp. 12 % (3) 3.1 % (4) 0.082
Enterobacter spp 4 % (1) 2.3 % (3) 0.506
Escherichia coli 8 % (2) 8.5 % (11) 1.000
Serratia marcescens 4 % (1) 3.1 % (4) 0.587
Pseudomonas spp. 0 4.6 % (6) 0.590
Klebsiella spp. 12 % (3) 2.3 % (3) 0.052
Proteus mirabilis 0 4.6 % (6) 0.590
Candida spp. 20 % (5) 1.5 % (2) 0.001
Others 0 14.6 % (19) 0.044
Bold writing indicates significant values
MRSA methicillin-resistant staphylococcus aureus, CNS coagulase negative
staphylococci; others: Citrobacter youngae, Stenotrophomonas maltophilia,
Aspergillus fumigatus, Streptococcus agalactiae, Morganella morganii,
Haemophilus influenzae, Citrobacter braakii, Citrobacter koseri, Saccharomyces
cerevisiae, Acinetobacter gyllenbergii and Lactobacillus curvatus
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also be descriptive if there are ethical and practical limi-
tations. Additionally, SWI registries would enhance data
collection and aggregation and could be used to gain
new insights on the topic.
Due to the small number of patients with simultan-
eous SWI and PDT, it was not possible to identify risk
factors for SWIs caused by cross-infection.
As a matter of fact, PDT is limited to critically ill pa-
tients. Therefore a comparison of patients suffering SWI
with or without PDT leads to a heterogeneous distribu-
tion of preoperative risk factors, limiting comparability
of outcomes and postoperative characteristics. We em-
phasized this by highlighting the preoperative differences
between groups in Table 1.
Fig. 5 Correlation between time of performing PDT and SWI
Fig. 6 Correlation between duration of ventilation through PDT and SWI
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In the routine microbiological tests of tracheal secre-
tions in our laboratory, not all bacteria of normal upper
airways flora were directly identified. Therefore, they
were not mentioned separately in the microbiological re-
ports. Many pathogens belonging to normal upper air-
way flora are potential pathogens that can cause an SWI.
Therefore, the rate of cross-infection could be higher
than what we could detect.
Conclusion
The incidence of microbial cross-infection from a PDT
to a sternal wound in our study was high. We could not
detect any correlation between the time of performing a
PDT and occurrence of an SWI. According to our data,
PDT seems to increase the incidence of SWI, especially
caused by Candida spp., after cardiac surgery, which re-
sults in a prolonged hospital stay. In high-risk patients
on long-term mechanical ventilation early antifungal
prophylaxis after a PDT might be reasonable as soon as
an SWI is suspected in order to mitigate dire complica-
tions of a candida SWI.
Abbreviations
BMI: mean body mass index; CABG: coronary artery bypass grafting;
CDC: Centers for Disease Control and Prevention; CNS: coagulase-negative
staphylococci; CPB: cardiopulmonary bypass time; CT: computed
tomography; DSWI: deep sternal wound infection; E. coli: escherichia coli;
IABP: intra-aortic balloon; PAD: peripheral artery disease; PDT: percutaneous
dilatational tracheostomy; spp.: species; S. aureus: staphylococcus aureus;
SSWI: superficial sternal wound infection; STS: The Society of Thoracic
Surgeons’ risk models; SD: standard deviation; SWI: sternal wound infection.
Competing interests
The author(s) declare that they have no competing interests.
Authors’ contributions
LT and RZ designed the study and developed the database. LT and RZ wrote
the manuscript. LT and RZ performed the statistical analyses and drafted the
manuscript. AG critically revised the statistical analysis, the study design and
the manuscript. AM critically revised the manuscript in cooperation with the
co-authors and interpreted the data. HH critically revised the microbiological
findings. RA, as the department chair, supported this study and participated
in designing the study. RA and JS critically revised the manuscript. RZ collected
the patient data. All the authors have read and approved the submitted version
of the manuscript.
Author details
1Department of Thoracic and Cardiovascular Surgery, University Hospital
RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany. 2Department of
Infection Control and Infectious Diseases, University Hospital RWTH Aachen,
Aachen, Germany.
Received: 13 May 2015 Accepted: 28 October 2015
References
1. Diez C, Koch D, Kuss O, Silber RE, Friedrich I, Boergermann J. Risk factors for
mediastinitis after cardiac surgery - a retrospective analysis of 1700 patients.
J Cardiothorac Surg. 2007;2:23. doi:10.1186/1749-8090-2-23.
2. Hollenbeak CS, Murphy DM, Koenig S, Woodward RS, Dunagan WC, Fraser VJ.
The clinical and economic impact of deep chest surgical site infections
following coronary artery bypass graft surgery. Chest. 2000;118(2):397–402.
3. Ridderstolpe L, Gill H, Granfeldt H, Ahlfeldt H, Rutberg H. Superficial and
deep sternal wound complications: incidence, risk factors and mortality. Eur
J Cardiothorac Surg. 2001;20(6):1168–75.
4. Salehi Omran A, Karimi A, Ahmadi SH, Davoodi S, Marzban M, Movahedi N, et
al. Superficial and deep sternal wound infection after more than 9000 coronary
artery bypass graft (CABG): incidence, risk factors and mortality.
BMC Infect Dis. 2007;7:112. doi:10.1186/1471-2334-7-112.
5. Gardlund B, Bitkover CY, Vaage J. Postoperative mediastinitis in cardiac
surgery - microbiology and pathogenesis. Eur J Cardiothorac Surg.
2002;21(5):825–30.
6. Mekontso-Dessap A, Kirsch M, Brun-Buisson C, Loisance D. Poststernotomy
mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant
and methicillin-susceptible cases. Clin Infect Dis. 2001;32(6):877–83.
doi:10.1086/319355.
7. Modrau IS, Ejlertsen T, Rasmussen BS. Emerging role of Candida in deep
sternal wound infection. Ann Thorac Surg. 2009;88(6):1905–9.
doi:10.1016/j.athoracsur.2009.08.012.
8. Mossad SB, Serkey JM, Longworth DL, Cosgrove 3rd DM, Gordon SM.
Coagulase-negative staphylococcal sternal wound infections after open
heart operations. Ann Thorac Surg. 1997;63(2):395–401.
9. Munoz P, Menasalvas A. Bernaldo de Quiros JC, Desco M, Vallejo JL, Bouza E.
Postsurgical mediastinitis: a case-control study. Clin Infect Dis. 1997;25(5):1060–4.
10. San Juan R, Chaves F, Lopez Gude MJ, Diaz-Pedroche C, Otero J, Cortina
Romero JM, et al. Staphylococcus aureus poststernotomy mediastinitis:
description of two distinct acquisition pathways with different potential
preventive approaches. J Thorac Cardiovasc Surg. 2007;134(3):670–6.
doi:10.1016/j.jtcvs.2007.04.010.
11. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for
nosocomial infections, 1988. Am J Infect Control. 1988;16(3):128–40.
12. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization
and subsequent infections in critically ill surgical patients. Ann Surg.
1994;220(6):751–8.
13. Playford EG, Webster AC, Sorrell TC, Craig JC. Antifungal agents for preventing
fungal infections in non-neutropenic critically ill patients. Cochrane Database
Syst Rev. 2006;(1):Cd004920. doi:10.1002/14651858.CD004920.pub2.
14. Byhahn C, Rinne T, Halbig S, Albert S, Wilke HJ, Lischke V, et al. Early
percutaneous tracheostomy after median sternotomy. J Thorac Cardiovasc
Surg. 2000;120(2):329–34. doi:10.1067/mtc.2000.108161.
15. Hubner N, Rees W, Seufert K, Bockelmann M, Christmann U, Warnecke H.
Percutaneous dilatational tracheostomy done early after cardiac surgery–
outcome and incidence of mediastinitis. Thorac Cardiovasc Surg.
1998;46(2):89–92. doi:10.1055/s-2007-1010196.
16. Stamenkovic SA, Morgan IS, Pontefract DR, Campanella C. Is early tracheostomy
safe in cardiac patients with median sternotomy incisions? Ann Thorac Surg.
2000;69(4):1152–4.
17. Westphal K, Byhahn C, Rinne T, Wilke HJ, Wimmer-Greinecker G, Lischke V.
Tracheostomy in cardiosurgical patients: surgical tracheostomy versus
ciaglia and fantoni methods. Ann Thorac Surg. 1999;68(2):486–92.
18. Park H, Kent J, Joshi M, Zhu S, Bochicchio GV, Henry S, et al. Percutaneous
versus open tracheostomy: comparison of procedures and surgical site
infections. Surg Infect (Larchmt). 2013;14(1):21–3. doi:10.1089/sur.2011.059.
19. Sun L, Boodhwani M, Baer H, McDonald B. The association between
tracheostomy and sternal wound infection in postoperative cardiac surgery
patients. Can J Anaesth. 2013;60(7):684–91. doi:10.1007/s12630-013-9950-6.
20. Provan JL, Austen WG. The role of elective tracheostomy after open-heart
surgery. Ann Thorac Surg. 1966;2(3):358–67.
21. Marshall RD. A review of the management of 140 elective tracheostomies
following open-heart surgery. Thorax. 1969;24(1):78–83.
22. Diehl JL, El Atrous S, Touchard D, Lemaire F, Brochard L. Changes in the
work of breathing induced by tracheotomy in ventilator-dependent
patients. Am J Respir Crit Care Med. 1999;159(2):383–8. doi:10.1164/
ajrccm.159.2.9707046.
23. Nieszkowska A, Combes A, Luyt CE, Ksibi H, Trouillet JL, Gibert C, et al.
Impact of tracheotomy on sedative administration, sedation level, and
comfort of mechanically ventilated intensive care unit patients. Crit Care
Med. 2005;33(11):2527–33.
24. Bacchetta MD, Girardi LN, Southard EJ, Mack CA, Ko W, Tortolani AJ, et al.
Comparison of open versus bedside percutaneous dilatational tracheostomy
in the cardiothoracic surgical patient: outcomes and financial analysis. Ann
Thorac Surg. 2005;79(6):1879–85. doi:10.1016/j.athoracsur.2004.10.042.
25. Gaudino M, Losasso G, Anselmi A, Zamparelli R, Schiavello R, Possati G. Is
early tracheostomy a risk factor for mediastinitis after median sternotomy?
J Card Surg. 2009;24(6):632–6. doi:10.1111/j.1540-8191.2009.00907.x.
Tewarie et al. Journal of Cardiothoracic Surgery  (2015) 10:155 Page 8 of 8
